(Q36814479)

16 August 2017

A practical guide of the Southwest Oncology Group to measure malignant pleural mesothelioma tumors by RECIST and modified RECIST criteria (English)

1 reference

malignant pleural mesothelioma

16 August 2017

1 reference

5

David Gandara

1 reference

16 August 2017

Anne S Tsao

1

1 reference

16 August 2017

Linda Garland

2

1 reference

16 August 2017

Mary Redman

3

1 reference

16 August 2017

Kemp Kernstine

4

1 reference

16 August 2017

Edith M Marom

6

1 reference

16 August 2017

1 March 2011

1 reference

Journal of Thoracic Oncology

16 August 2017

1 reference

16 August 2017

6

1 reference

16 August 2017

3

1 reference

16 August 2017

598-601

1 reference

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3643692

Assessment of tumor response in malignant pleural mesothelioma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3643692

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3643692

Assessment of therapy responses and prediction of survival in malignant pleural mesothelioma through computer-aided volumetric measurement on computed tomography scans.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3643692

Evaluation of lymph nodes with RECIST 1.1.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3643692

Therapy response in malignant pleural mesothelioma-role of MRI using RECIST, modified RECIST and volumetric approaches in comparison with CT.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3643692

CT, RECIST, and malignant pleural mesothelioma.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3643692

Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3643692

Modified RECIST criteria for assessment of response in malignant pleural mesothelioma

5 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21270668

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Three-dimensional evaluation of chemotherapy response in malignant pleural mesothelioma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21270668

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/JTO.0B013E318208C83D

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

21270668

1 reference